Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anneke M T van Lynden-van Nes"'
Autor:
Lotte S Spekhorst, Celeste M Boesjes, Laura Loman, Nicolaas P A Zuithoff, Daphne S Bakker, Esmé Kamphuis, Marijke Kamsteeg, Inge Haeck, Albert J Oosting, Paula P M van Lumig, Anneke M T van Lynden-van Nes, Ron A Tupker, Annebeth Flinterman, Floor M Garritsen, Wouter R H Touwslager, Marjolein S de Bruin-Weller, Marie-Louise Schuttelaar, Marlies de Graaf
Publikováno v:
British Journal of Dermatology.
Background Limited data is available regarding patient-centered dosing of dupilumab for atopic dermatitis (AD) in daily practice. Objectives To evaluate our patient-centered dupilumab dosing regimen in daily practice, to assess prognostic factors for
Autor:
Lotte S. Spekhorst, Marlies de Graaf, Lisa P. van der Rijst, Nicolaas P. A. Zuithoff, René C. Schweizer, Marijke Kamsteeg, Inge Haeck, Anneke M. T. van Lynden‐van Nes, Paula van Lumig, Geertruida L. E. Romeijn, Marie‐Louise Schuttelaar, Marjolein S. de Bruin‐Weller
Publikováno v:
Clinical and Translational Allergy, 13, 1
Clinical and Translational Allergy, 13(1):e12219. BioMed Central Ltd
Clinical and Translational Allergy, 13
Clinical and Translational Allergy, 13(1):e12219. BioMed Central Ltd
Clinical and Translational Allergy, 13
Contains fulltext : 291229.pdf (Publisher’s version ) (Open Access) 01 januari 2023
Autor:
Lotte S. Spekhorst, Marlies de Graaf, Nicolaas P. A. Zuithoff, Juul M. P. A. van den Reek, Marijke Kamsteeg, Celeste M. Boesjes, Geertruida L. E. Romeijn, Laura Loman, Inge Haeck, Albert J. Oosting, Astrid de Boer-Brand, Wouter R. H. Touwslager, Annebeth Flinterman, Anneke M. T. van Lynden-van Nes, Antoni H. Gostynski, Marjolein S. de Bruin-Weller, Marie-Louise Schuttelaar
Publikováno v:
JAMA Dermatology, 158(9), 1048-1056. AMA
Jama dermatology, 158(9). AMER MEDICAL ASSOC
Jama Dermatology, 158, 1048-1056
Jama Dermatology, 158, 9, pp. 1048-1056
Jama dermatology, 158(9). AMER MEDICAL ASSOC
Jama Dermatology, 158, 1048-1056
Jama Dermatology, 158, 9, pp. 1048-1056
ImportanceLong-term data on dupilumab drug survival in patients with atopic dermatitis (AD) are scarce. Furthermore, little is known about the factors associated with drug survival of dupilumab in AD.ObjectiveTo describe the drug survival of dupiluma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b725cd18292e51e4cdac82908189b541
https://cris.maastrichtuniversity.nl/en/publications/af1804c3-844a-41d1-aa89-1fe8ea7a1e49
https://cris.maastrichtuniversity.nl/en/publications/af1804c3-844a-41d1-aa89-1fe8ea7a1e49